Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 31 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 9657292

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

  2. US 9657269

    Regulatory B cells (tBREGS) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

  3. US 9657096

    Human domain antibodies against components of the human insulin-like growth factor (IGF) system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

  4. US 9649339

    LAT adapter molecule for enhanced T-cell signaling and method of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 16, 2017 · Expires May 11, 2037

    granted

  5. US 9650352

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 16, 2017 · Expires May 11, 2037

    granted

  6. US 9644179

    Use of PDL1 expressing cells to convert T cells into regulatory T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 9, 2017 · Expires May 4, 2037

    granted

  7. US 9644216

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 9, 2017 · Expires May 4, 2037

    granted

  8. US 9629897

    Methods of producing and using regulatory B-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  9. US 9631192

    Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  10. US 9629899

    Targeted cargo protein combination therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  11. US 9624475

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  12. US 9623020

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  13. US 9624306

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  14. US 9617229

    Phenylmorpholines and analogues thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  15. US 9616073

    Method for on-demand contraception

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  16. US 9610338

    Serologic correlates of protection against bacillus anthracis infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  17. US 9605044

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  18. US 9593136

    Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  19. US 9592207

    Intranasal administration of ketamine to treat depression

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  20. US 9580492

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  21. US 9579302

    Ketone bodies to protect tissues from damage by ionizing radiation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  22. US 9579333

    Inhibition of HIV infection through chemoprophyalxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  23. US 9566329

    Live, attenuated rubella vector to express vaccine antigens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  24. US 9567387

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.